Extracellular vesicles as orchestrators of arterial and venous thrombosis: A unified mechanistic model
Vascular Pharmacology · 2026
DOI: 10.1016/j.vph.2026.107605 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Vascular Pharmacology, 2026. Verfasst von Chunlan Xia und 9 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai TCM-integrated Hospital, Shanghai University of TCM, Shanghai 200082, China. Hauptthemen laut MEDLINE: Extracellular Vesicles, Venous Thrombosis, Thrombosis, Arteries. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 79 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Shanghai University of Traditional Chinese Medicine.
Abstract (Originalsprache)
Extracellular vesicles (EVs) function as the central mechanobiological orchestrators connecting vascular inflammation and hemostasis. In this review, we propose a unified mechanistic model wherein EV thrombogenicity is governed by convergent catalytic switches: phosphatidylserine (PS) externalization, which scaffolds tenase and prothrombinase assembly, and the structural "decryption" of Tissue Factor (TF) via membrane reorganization and thiol-disulfide exchange. While these molecular drivers are universal, their pathological manifestations diverge strictly by hemodynamic context. In the high-shear arterial environment, EVs act as stress transducers; platelet-EVs leverage von Willebrand factor-GPIb interactions to drive acute occlusion. Conversely, under venous stasis, an immunothrombotic axis dominates; here, hypoxic endothelial- and leukocyte-EVs shuttle mitochondrial DAMPs to potentiate Neutrophil Extracellular Trap (NET) formation, scaffolding the fibrin-rich "red thrombus." Despite this mechanistic clarity, clinical translation is impeded by methodological constraints, particularly the confounding interference of lipoproteins (e.g., chylomicrons) in functional assays. Ultimately, harnessing EVs as "liquid biopsy" biomarkers or therapeutic vectors requires a paradigm shift from particle enumeration to functional phenotyping, alongside rigorous safety engineering to resolve the inherent thrombogenic paradox of EV-based interventions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Shanghai TCM-integrated Hospital, Shanghai University of TCM, Shanghai 200082, China.
- Shanghai TCM-integrated Hospital, Shanghai University of TCM, Shanghai 200082, China; Institute of Vascular Anomalies, Shanghai TCM-Integrated Hospital, Shanghai University of TCM, Shanghai 200082, China.
- Department of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing 211100, China.
- Shanghai TCM-integrated Hospital, Shanghai 200082, China.
- Institute of Vascular Anomalies, Shanghai TCM-Integrated Hospital, Shanghai University of TCM, Shanghai 200082, China; Department of Public Health, International College, Krirk University, Bangkok, Thailand. Electronic…
- Shanghai TCM-integrated Hospital, Shanghai 200082, China. Electronic address: xuchenqin@shutcm.edu.cn.
Förderung
- National Natural Science Foundation of China
- Shanghai University of Traditional Chinese Medicine
Zitieren
APA
Xia, C., Xu, C., Liu, Y., Feng, X., Le, Y., Xu, H., Qi, F., Liang, Z., Chen, J., & Li, J. (2026). Extracellular vesicles as orchestrators of arterial and venous thrombosis: A unified mechanistic model. Vascular Pharmacology. https://doi.org/10.1016/j.vph.2026.107605
Vancouver
Xia C, Xu C, Liu Y, Feng X, Le Y, Xu H, et al. Extracellular vesicles as orchestrators of arterial and venous thrombosis: A unified mechanistic model. Vascular Pharmacology. 2026. doi:10.1016/j.vph.2026.107605
BibTeX
@article{Xia2026,
author = {Xia, Chunlan and Xu, Chenqin and Liu, Yumiao and Feng, Xia and Le, Yi and Xu, Hongtao and Qi, Fei and Liang, Zhiqiang and Chen, Jian and Li, Ji},
title = {Extracellular vesicles as orchestrators of arterial and venous thrombosis: A unified mechanistic model},
journal = {Vascular Pharmacology},
year = {2026},
doi = {10.1016/j.vph.2026.107605}
}
EUVIMED